About ZZ Biotech
ZZ Biotech is a Healthcare company based in Houston (United States) founded in 2006. Genetically engineered proteins for stroke and brain disorders are developed. ZZ Biotech has completed 1 acquisition, including Bioatrix. Its chief executive, as recorded, is Kent Pryor. ZZ Biotech offers products and services including 3K3A-APC. Its focus areas include Life Sciences, Neurology, Drugs and Stroke. Its legal entity is ZZ Biotech, LLC. Its competitors include Basking Biosciences, Remedy Pharmaceuticals and Remedium Bio; 3 of its 3 listed competitors have raised funding.
Company details
ZZ Biotech was founded in 2006 in Houston, United States, within the biotechnology sector. Focus is placed on biological therapies for conditions affecting the aging and damaged brain, such as stroke and neurodegenerative diseases. The lead product, 3K3A-APC, represents a modified form of activated protein C and is undergoing phase 2 clinical trials. Functions related to cell protection, inflammation reduction, and blood clotting regulation are attributed to this candidate.
- Headquarters Houston, United States
- SectorsHealthcare
- Email••••••••
- Website zzbiotech.com
- Social LinkedIn
- Legal Name Zz Biotech, Llc
Products & Services of ZZ Biotech
ZZ Biotech offers a comprehensive portfolio of products and services, including 3K3A-APC.
Genetically engineered variant of human protein C for therapeutic applications.
Funding Insights of ZZ Biotech
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of ZZ Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2014 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in ZZ Biotech
ZZ Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NIH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for ZZ Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ZZ Biotech
8 people are tracked at ZZ Biotech (5 in leadership, 3 in board & advisors).
| Name | Role | Group |
|---|---|---|
Kent Pryor | CEO | Leadership |
Kent E. Pryor | CEO & Director | Leadership |
Susan Willingham | Director, Finance | Leadership |
Craig Van De Mark | Director & VP, Legal | Leadership |
Lisa Koch-Hulle | Head, Regulatory Affairs | Leadership |
Joseph J. Romano | Executive Chairman | Board & advisors |
Tadeusz Wellisz | Director | Board & advisors |
Jay Hennock | Director | Board & advisors |
Complete people profiles for ZZ Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ZZ Biotech
ZZ Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Bioatrix.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developing activated protein C (aPC)-based products primarily for wound healing | bioatrix.com | Sydney, Australia | 2012 | Jan 2016 | •••• |
Complete acquisition details for ZZ Biotech
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ZZ Biotech
3 dated milestones of ZZ Biotech across 10 years, from founding to its latest funding, stage changes and deals.
- Founded ZZ Biotech is founded.
- Funding First funding round.
- Acquisition Acquires Bioatrix.
Competitors of ZZ Biotech
ZZ Biotech has 3 listed competitors in our database, 3 of them funded. They include Basking Biosciences, Remedy Pharmaceuticals and Remedium Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| baskingbiosciences.com | 2019 | Columbus, United States | $89.8M | 3 | Therapeutics for ischemic stroke treatment are developed. | |
| remedypharmaceuticals.com | 2004 | New York, United States | $22.76M | 6 | Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury. | |
| remedium-bio.com | 2020 | Needham, United States | $3.5M | Gene therapies for immune and age-related conditions are developed. |
Detailed competitors of ZZ Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as ZZ Biotech (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zz Biotech
Complete news archive for ZZ Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZZ Biotech
ZZ Biotech was founded in 2006 and raised its 1st funding round 8 years after it was founded.
ZZ Biotech is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Kent Pryor is the CEO of ZZ Biotech, as recorded in our data.
ZZ Biotech was founded in 2006 in Houston, United States, within the biotechnology sector. Focus is placed on biological therapies for conditions affecting the aging and damaged brain, such as stroke and neurodegenerative diseases. The lead product, 3K3A-APC, represents a modified form of activated protein C and is undergoing phase 2 clinical trials. Functions related to cell protection, inflammation reduction, and blood clotting regulation are attributed to this candidate.
ZZ Biotech's top competitors include Remedy Pharmaceuticals, Basking Biosciences and Remedium Bio.
ZZ Biotech offers 3K3A-APC.
ZZ Biotech has made 1 acquisition, including Bioatrix.
ZZ Biotech has 1 investor. Key investors include NIH.
ZZ Biotech operates through Zz Biotech, Llc.